Halozyme Therapeutics (NASDAQ:HALO) COO Cortney Caudill Sells 8,857 Shares

NodeGuardian

2026-03-28 09:40:51

Abstract generation in progress

Halozyme Therapeutics COO Cortney Caudill sold 8,857 shares of the company’s stock for over $599,000 on March 10th, following a sale of 20,000 shares on March 9th. These transactions reduced her direct ownership in the company significantly. The sales occurred shortly after Halozyme Therapeutics reported a quarterly EPS miss, though revenue exceeded estimates, and analyst ratings for the stock are currently mixed.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes